Linical Co. Ltd. | Ownership

Companies that own Linical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
264,600
1.07%
200
0%
07/31/2018
Nomura Asset Management Co., Ltd.
205,497
0.83%
3,099
0%
07/31/2018
SBI Asset Management Co., Ltd.
171,800
0.69%
170,300
0.38%
06/05/2017
Dimensional Fund Advisors LP
126,100
0.51%
8,600
0%
04/30/2018
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
111,665
0.45%
-78,934
0%
07/31/2018
Daiwa Asset Management Co. Ltd.
100,100
0.41%
-5,199
0%
07/31/2018
Nikko Asset Management Co., Ltd.
91,098
0.37%
-202
0%
08/20/2018
Norges Bank Investment Management
66,200
0.27%
66,200
0%
12/31/2017
Asset Management One Co., Ltd.
32,399
0.13%
-34,901
0%
04/20/2018
Sawakami Asset Management, Inc.
14,899
0.06%
14,899
0.01%
08/23/2017

About Linical Co.

View Profile
Address
Shin-Osaka Brick Building, 10/F
Osaka Osaka 532
Japan
Employees -
Website http://www.linical.co.jp
Updated 07/08/2019
Linical Co., Ltd. engages in pharmaceutical contract research projects providing consulting, monitoring, and quality control services to pharmaceutical companies. It operates through the Contract Research Organization (CRO) Business and Contract Sales Organization (CSO) Business segments. The CRO Business segment provides outsourced pharmaceutical development services.